TLP

Tri Locum Partners Portfolio holdings

AUM $330M
This Quarter Return
+9.29%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
10 Year Return
AUM
$314M
AUM Growth
+$314M
Cap. Flow
+$28.3M
Cap. Flow %
9.02%
Top 10 Hldgs %
74.73%
Holding
80
New
15
Increased
11
Reduced
3
Closed
50

Sector Composition

1 Healthcare 92.99%
2 Technology 4.64%
3 Communication Services 0%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AVDL
26
Avadel Pharmaceuticals
AVDL
$1.42B
$1.45M 0.36%
+160,256
New +$1.45M
IMTX icon
27
Immatics
IMTX
$662M
$1.37M 0.34%
+121,743
New +$1.37M
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$1.22M 0.3%
+68,472
New +$1.22M
EOLS icon
29
Evolus
EOLS
$477M
$1.05M 0.26%
+81,025
New +$1.05M
AMRX icon
30
Amneal Pharmaceuticals
AMRX
$3B
$939K 0.23%
+139,470
New +$939K
BHVN
31
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-19,832
Closed -$1.7M
GWPH
32
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-40,159
Closed -$4.64M
KDMN
33
DELISTED
Kadmon Holdings, Inc.
KDMN
-15,618
Closed -$65K
CCXI
34
DELISTED
ChemoCentryx, Inc.
CCXI
-166,077
Closed -$10.3M
ONCT
35
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-285,714
Closed -$1.4M
CBAY
36
DELISTED
Cymabay Therapeutics
CBAY
-62,000
Closed -$356K
AXNX
37
DELISTED
Axonics, Inc. Common Stock
AXNX
-64,378
Closed -$3.21M
ZLAB icon
38
Zai Lab
ZLAB
$3.48B
-62,235
Closed -$8.42M
VZ icon
39
Verizon
VZ
$184B
-5,437
Closed -$319K
VTRS icon
40
Viatris
VTRS
$12.3B
-1,046,794
Closed -$19.6M
UL icon
41
Unilever
UL
$158B
-3,725
Closed -$225K
TU icon
42
Telus
TU
$25.1B
-11,793
Closed -$234K
TBPH icon
43
Theravance Biopharma
TBPH
$691M
-49,373
Closed -$877K
TARA icon
44
Protara Therapeutics
TARA
$125M
-39,225
Closed -$950K
RIGL icon
45
Rigel Pharmaceuticals
RIGL
$710M
-14,557
Closed -$51K
PG icon
46
Procter & Gamble
PG
$370B
-3,210
Closed -$447K
PEN icon
47
Penumbra
PEN
$10.5B
-1,695
Closed -$297K
NTLA icon
48
Intellia Therapeutics
NTLA
$1.26B
-56,402
Closed -$3.07M
NBIX icon
49
Neurocrine Biosciences
NBIX
$13.5B
-7,178
Closed -$688K
MRSN icon
50
Mersana Therapeutics
MRSN
$34.8M
-271,974
Closed -$7.24M